Form 8-K - Current report:
SEC Accession No. 0001493152-23-002389
Filing Date
2023-01-25
Accepted
2023-01-25 08:00:26
Documents
12
Period of Report
2023-01-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32540
  Complete submission text file 0001493152-23-002389.txt   209108

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20230124.xsd EX-101.SCH 3245
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20230124_lab.xml EX-101.LAB 34916
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20230124_pre.xml EX-101.PRE 22801
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3738
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 23549851
SIC: 2834 Pharmaceutical Preparations